Company intelligence / Profile preview

CJ Corporation

Seoul, Seoul, South Koreacj.net ↗
Ownership
Private
Development stage
Other
01

Overview

CJ Corporation is a major South Korean conglomerate with significant activities in life sciences through its pharmaceutical and biotech arms. Its subsidiary companies have developed antibiotics, vaccines—including one of the world’s first alpha-interferon drugs—and are now global leaders in microbiome-based therapeutics R&D. The group leverages advanced bioinformatics platforms for both diagnostics and therapeutic development. Clinical results from recent years include ongoing multinational trials targeting solid tumors with live biotherapeutic products/microbiome therapies; historical success includes commercialization of vaccines like Hepaccine-B against hepatitis B.

Therapeutic areas
OncologyGastroenterologyNeurologyInfectious Diseases
Modalities
Small moleculeVaccineBiologicMicrobial therapyAntibioticsRecombinant protein
Industry
Biotech
02

Drug pipeline

1 asset

Smallpox Vaccine MRC-5

3
03

Partnerships

Active collaborations with Big Pharma on joint research/trials/exportation of technology from the microbiome pipeline (specific partners not named publicly)

Beyond the preview

Go deeper on CJ Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CJ Corporation.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call